Advisor Group Holdings, Inc. Neogenomics Inc Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,928 shares of NEO stock, worth $49,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,928

Previous 5,709 13.68%

Holding current value

$49,772

Previous $41,000 12.2%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	SELL	$6.4 - $10.27 $4,998 - $8,020	-781 Reduced 13.68%	4,928 $36,000
Q2 2025 Aug 13, 2025	BUY	$6.4 - $10.27 $5,708 - $9,160	892 Added 18.52%	5,709 $41,000
Q1 2025 May 12, 2025	SELL	$9.09 - $18.61 $15,525 - $31,785	-1,708 Reduced 26.18%	4,817 $45,000
Q4 2024 Jun 06, 2025	BUY	$13.0 - $18.43 $17,485 - $24,788	1,345 Added 27.92%	6,162 $101,000
Q4 2024 Feb 07, 2025	SELL	$13.0 - $18.43 $11,895 - $16,863	-915 Reduced 12.3%	6,525 $107,000
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $9,045 - $11,967	-675 Reduced 8.32%	7,440 $109,000
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $79,816 - $96,748	-6,135 Reduced 43.05%	8,115 $112,000
Q1 2024 May 10, 2024	SELL	$14.06 - $16.79 $416,021 - $496,799	-29,589 Reduced 67.49%	14,250 $224,000
Q4 2023 Feb 12, 2024	BUY	$11.67 - $20.73 $143,926 - $255,663	12,333 Added 39.14%	43,839 $709,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $67,177 - $98,692	5,529 Added 21.28%	31,506 $387,000
Q2 2023 Aug 10, 2023	SELL	$14.1 - $19.83 $303,220 - $426,444	-21,505 Reduced 45.29%	25,977 $417,000
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $244,030 - $522,154	26,846 Added 130.09%	47,482 $826,000
Q4 2022 Feb 10, 2023	SELL	$6.45 - $12.07 $16,718 - $31,285	-2,592 Reduced 11.16%	20,636 $190,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $12,434 - $20,423	-1,582 Reduced 6.38%	23,228 $199,000
Q2 2022 Aug 10, 2022	BUY	$7.06 - $13.97 $34,883 - $69,025	4,941 Added 24.87%	24,810 $201,000
Q1 2022 May 04, 2022	SELL	$12.15 - $35.28 $62,924 - $182,715	-5,179 Reduced 20.68%	19,869 $1.07 Million
Q3 2021 Nov 05, 2021	SELL	$41.66 - $52.52 $150,850 - $190,174	-3,621 Reduced 12.63%	25,048 $1.21 Million
Q2 2021 Aug 02, 2021	BUY	$36.62 - $51.69 $281,754 - $397,702	7,694 Added 36.68%	28,669 $1.29 Million
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $1.46 Million - $2.1 Million	-35,050 Reduced 62.56%	20,975 $1.01 Million
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $651,063 - $1.02 Million	-18,045 Reduced 24.36%	56,025 $3.02 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $219,449 - $267,087	-6,598 Reduced 8.18%	74,070 $2.43 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $402,152 - $515,273	-16,611 Reduced 17.08%	80,668 $2.5 Million
Q1 2020 May 18, 2020	BUY	$20.5 - $34.53 $1.99 Million - $3.36 Million	97,279 New	97,279 $2.61 Million

Others Institutions Holding NEO

# of Institutions

306

Shares Held

127M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.27B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Neogenomics Inc Transaction History